跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
泌尿學科
醫學院
醫學系
電話
886-6-2353535 ext. 5251
電子郵件
[email protected]
網站
https://urology-med.ncku.edu.tw
Postal address
在地圖上顯示
概覽
指紋
網路
概要
(5)
專案
(63)
研究成果
(375)
指紋
查看啟用 泌尿學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Transitional Cell Carcinoma
100%
Nephroureterectomy
57%
Bladder
56%
Prostate Cancer
40%
Upper Urinary Tract
39%
Neoplasm
34%
Bladder Cancer
28%
Kidney Stone
27%
Biopsy Technique
26%
Lymphocyte
24%
Azoospermia
24%
Transrectal Ultrasonography
22%
Percutaneous Nephrolithotomy
21%
Prostate Biopsy
21%
Urothelial Cancer
21%
Recurrent Disease
20%
Infection
19%
Quality of Life
18%
Malignant Neoplasm
18%
Kidney Function
18%
Bleeding
17%
Cancer
17%
Biological Marker
17%
Prostate Hypertrophy
16%
Calcium Oxalate
16%
Diseases
16%
Blood Flow
16%
Supine Position
16%
Cohort Analysis
16%
Messenger RNA
15%
Urologist
15%
Cystectomy
15%
Pedicle
14%
Enzalutamide
14%
Prostate Specific Antigen
13%
Extracorporeal Shock Wave Lithotripsy
13%
Urinary System
13%
Pelvis
12%
Chronic Kidney Disease
12%
Overall Survival
12%
Hazard Ratio
12%
Cancer Diagnosis
12%
Protein Expression
11%
Superficial Bladder Cancer
11%
Clinical Significance
11%
Urinary Retention
11%
Exenteration
10%
Stress Incontinence
10%
Systemic Immune Inflammation Index
10%
Interstitial Cystitis
10%
Isotopes of Calcium
10%
Urothelium
10%
Lipid Metabolism
10%
Receptor Protein
10%
Uric Acid Stone
10%
Osteopontin
10%
Transurethral Resection
10%
Antigen Expression
10%
Fournier Gangrene
10%
Calcium Oxalate Stone
10%
Clinical Feature
10%
Recurrence Free Survival
10%
Prognostic Factor
10%
Urinary Tract
10%
Multivariate Analysis
10%
Sperm Retrieval
9%
Progression Free Survival
9%
Methylation
9%
Urodynamics
9%
Urine Cytology
9%
Prostaglandin E1
8%
Chromosome Deletion Y
8%
Immunohistochemistry
8%
Echography
8%
Atorvastatin
8%
Prostate Disease
8%
Disease Exacerbation
8%
Sperm Motility
8%
Testes
7%
Cancer Staging
7%
Glomerular Filtration Rate
7%
Neutrophil
7%
Lymphovascular Invasion
7%
Corpus Cavernosum Penis
7%
Intracavernous Injection
7%
Hematoma
7%
Urolithiasis
7%
Diabetes Mellitus
6%
Proportional Hazards Model
6%
Radioisotope Renography
6%
Lower Urinary Tract Symptom
6%
Non Muscle Invasive Bladder Cancer
6%
Ureter
6%
Promoter Region
6%
Hydronephrosis
6%
Urology
6%
In Vitro
6%
Oncology
6%
Western Blot
6%
Comorbidity
6%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
58%
Neoplasm
49%
Transitional Cell Carcinoma
46%
Prostate Cancer
45%
Streptozotocin
33%
Diabetes Mellitus
30%
Kidney Stone
23%
Messenger RNA
20%
Bladder Tumor
19%
Enzalutamide
19%
Malignant Neoplasm
19%
Nephrolithiasis
16%
Calcium Oxalate Stone
16%
Cisplatin
15%
Chemotherapy
15%
Biological Marker
12%
Muscarinic Receptor
12%
Leporidae
11%
CD8 Antigen
10%
Hydronephrosis
10%
Prothymosin Alpha
10%
Spontaneously Hypertensive Rat
10%
Atorvastatin
10%
Nerve Growth Factor
10%
Phthalic Acid
10%
Protein P53
10%
Nitric Oxide
10%
Adenosine Triphosphate
10%
Tumor Recurrence
9%
Disease Exacerbation
9%
Wistar Rat
9%
Prostate Hypertrophy
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Recurrent Disease
8%
Calcium Oxalate
8%
Androgen
8%
Azoospermia
8%
Carcinogenesis
7%
Tumor Suppressor Protein
7%
Cholinergic Receptor Stimulating Agent
7%
Recurrence Free Survival
7%
Receptor Protein
7%
Diseases
7%
Cohort Study
7%
Progression Free Survival
7%
Neurotrophin Receptor P75
7%
Western Blot
7%
Aldose Reductase Inhibitor
6%
Noradrenalin
6%
Primary Tumor
6%
Hyperplasia
6%
Detrusor Dyssynergia
6%
Cancer Growth
6%
Ureter Stone
6%
Castration Resistant Prostate Cancer
6%
Obstruction
6%
Clinical Feature
6%
Kidney Injury
6%
Sex Hormone
5%
Epirubicin
5%
Vinblastine
5%
Methotrexate
5%
Dyslipidemia
5%
Sorbitol
5%
Drug Resistance
5%
Radioisotope
5%
Epalrestat
5%
Magnetic Nanoparticle
5%
Interferon
5%
Single Chain Fragment Variable Antibody
5%
Squash
5%
Fibroblast Growth Factor 9
5%
Antitumor Activity
5%
Transcription Factor Nrf2
5%
Short Hairpin RNA
5%
Uric Acid
5%
Chemical Carcinogenesis
5%
Tumor Marker
5%
Interstitial Cystitis
5%
Lower Urinary Tract Symptom
5%
Angiopoietin
5%
Intracavernous Injection
5%
Urine Retention
5%
Muscarinic M1 Receptor
5%
Thymosin
5%
Loperamide
5%
Buflomedil
5%
Prostate Disease
5%
Synapsin I
5%
Terazosin
5%
Neuropeptide Y
5%
Progesterone
5%
Arsenic Acid
5%
Hyperlipidemia
5%
Growth Differentiation Factor 15
5%
Nuclear Matrix Protein 22
5%
Receptor Subtype
5%
Iron Oxide Nanoparticle
5%
Cachexia
5%
Chymotrypsin A
5%
Keyphrases
Bladder Cancer
18%
Prostate
17%
Upper Urinary Tract
11%
Testicle
11%
Infertile Women
11%
Extravesical
10%
Supine Position
10%
Prostate Biopsy
10%
Streptozotocin-induced Diabetic Rats
10%
Incremental Neural Network
10%
Cdc25
10%
Rat Corpus Cavernosum
10%
Agmatine
10%
Deleted in Azoospermia
10%
End-diastolic Velocity
9%
Bladder Tumor
9%
Spermatogenic Failure
8%
Adrenoceptors
8%
Human Spermatogenesis
7%
Bladder Cuff
7%
Laparoscopic Partial Nephrectomy
7%
Intravesical Recurrence
7%
Androgen Receptor Antagonist
7%
Antibiotics
7%
Sertoli Cell-only Syndrome
7%
Maturation Arrest
7%
RNA Transcripts
7%
Azoospermia Factor
7%
Resection
6%
Hand-assisted
6%
Prostate Disease
6%
Antibiotic Susceptibility Testing
6%
Transrectal Ultrasound Image
6%
Doppler Ultrasonography
6%
Upper Tract Urothelial Carcinoma
6%
Post-biopsy Infections
6%
Azoospermic Men
6%
Imidazoline I2 Receptor
6%
Prostate Cancer Screening
6%
Gene Expression
6%
Stone Formers
6%
Expression Pattern
6%
Uric Acid Stones
5%
Bladder
5%
Ureteral Orifice
5%
Male Infertility
5%
Human Testis
5%
MBT-2
5%
Cancer Patients
5%
Transcript Level
5%
Distal Renal Tubule
5%
Gene Screening
5%
Ureteroscopic Lithotripsy
5%
Ultrasound Image
5%
Oct4 Expression
5%
P75 Neurotrophin Receptor (p75NTR)
5%
Surgical Trends
5%
Frame Comparison
5%
Urological Malignancies
5%
Clinical Frailty Scale
5%
Tyrosine Kinase Oncogene
5%
Metastatic Renal Cell Carcinoma (mRCC)
5%
Survival Analysis
5%
Female Stress Urinary Incontinence
5%
Ischemic Heart
5%
Electrogene Transfer
5%
SMARCB1
5%
Rhabdoid Features
5%
Pumpkin Seed Oil
5%
Prostate Growth
5%
Adjunction
5%
Flow Information
5%
Intratesticular Testosterone
5%
INI1
5%
Complete Removal
5%
HER2 Expression
5%
Dynamic MRI
5%
Renal Stone
5%
Signaling Axis
5%
Shock Wave Lithotripsy
5%
Personalized Therapy
5%
Peripheral Microcirculation
5%
Transurethral Microwave Thermotherapy
5%
Time Tracking
5%
Hilar
5%
Stone Fragmentation
5%
Ultrasound-based
5%
Short-term Experience
5%
Renal Hilum
5%
Pulse Oximeter
5%
Erythrocyte Oxidative Stress
5%
Ureteroscopic
5%
Ice Growth
5%
Cryosurgery
5%
Percutaneous Nephrolithotomy
5%
Stone Size
5%
Renal Staghorn Stones
5%
Blood Culture
5%
Obese Rats
5%
Sex-related Genes
5%